Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Country |
|
Opiates |
% inj |
Cocaine |
% inj |
Amphetamines |
% inj |
Ecstasy |
Hallucinogens |
% inj |
Cannabis |
Others |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Belgium |
(1) |
33.2 |
37.7 |
6.0 |
11.0 |
12.0 |
6.0 |
1.0 |
0.0 |
0.0 |
15.0 |
32.8 |
Czech Republic |
|
25.1 |
87.7 |
0.3 |
4.5 |
52.9 |
84.4 |
0.6 |
0.3 |
3.4 |
16.5 |
4.3 |
Denmark |
|
50.4 |
46.1 |
4.4 |
15.2 |
5.8 |
3.3 |
1.2 |
0.0 |
|
25.6 |
12.6 |
Germany |
(2) |
55.0 |
68.0 |
7.0 |
|
6.0 |
3.1 |
|
0.0 |
|
26.0 |
6.0 |
Greece |
|
88.8 |
51.9 |
1.5 |
15.1 |
0.0 |
|
0.4 |
0.1 |
0.0 |
7.4 |
1.8 |
Spain |
(3) |
59.0 |
24.0 |
26.0 |
9.0 |
1.0 |
9.0 |
1.0 |
0.1 |
14.0 |
11.0 |
1.9 |
France |
(4) |
70.6 |
|
5.8 |
|
0.3 |
|
1.1 |
0.3 |
|
17.6 |
4.3 |
Ireland |
(5) |
64.1 |
56.1 |
1.7 |
6.3 |
0.4 |
11.8 |
6.0 |
0.2 |
0.0 |
24.1 |
3.5 |
Italy |
|
76.3 |
66.9 |
8.9 |
14.9 |
0.2 |
1.9 |
0.8 |
0.1 |
|
10.3 |
3.4 |
Cyprus |
|
67.2 |
83.1 |
9.0 |
0.0 |
0.4 |
0.0 |
3.4 |
0.0 |
|
17.7 |
2.3 |
Latvia |
|
52.6 |
83.9 |
0.8 |
25.0 |
12.0 |
63.9 |
1.4 |
1.8 |
0.0 |
3.3 |
29.9 |
Lithuania |
|
78.8 |
|
0.1 |
|
2.5 |
|
|
0.2 |
0.5 |
|
18.4 |
Luxembourg |
|
76.0 |
64.0 |
11.0 |
45.0 |
0.0 |
|
0.0 |
0.0 |
|
8.0 |
5.0 |
Hungary |
|
17.1 |
65.2 |
0.9 |
6.1 |
3.0 |
25.4 |
2.1 |
0.6 |
2.4 |
25.2 |
51.1 |
Malta |
(6) |
77.6 |
77.7 |
6.9 |
15.6 |
0.0 |
|
0.8 |
0.2 |
0.0 |
14.3 |
0.2 |
Netherlands |
|
35.0 |
12.0 |
38.0 |
2.0 |
3.0 |
1.0 |
1.0 |
1.0 |
0.0 |
20.0 |
2.0 |
Austria |
(7) |
100.0 |
100.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Poland |
(8) |
30.3 |
|
0.8 |
|
8.1 |
|
|
0.5 |
|
3.3 |
57.0 |
Portugal |
(9) |
|
|
|
|
|
|
|
|
|
|
|
Slovenia |
(10) |
88.0 |
99.7 |
0.8 |
0.3 |
0.3 |
|
0.2 |
0.0 |
|
10.4 |
0.3 |
Slovakia |
|
51.8 |
80.9 |
0.8 |
25.0 |
17.2 |
37.9 |
0.5 |
0.5 |
9.1 |
14.0 |
15.2 |
Finland |
|
36.5 |
86.0 |
0.2 |
|
32.8 |
79.8 |
0.5 |
0.2 |
|
20.8 |
9.0 |
Sweden |
|
32.8 |
68.2 |
1.0 |
5.9 |
36.9 |
62.6 |
0.8 |
0.1 |
0.0 |
18.5 |
9.9 |
United Kingdom |
(11) |
72.0 |
49.0 |
9.0 |
6.0 |
3.0 |
29.0 |
1.0 |
0.1 |
7.0 |
10.0 |
4.9 |
Bulgaria |
|
95.6 |
79.1 |
0.5 |
0.0 |
0.5 |
0.0 |
0.0 |
0.0 |
|
2.0 |
1.4 |
Romania |
|
68.0 |
|
1.0 |
|
0.0 |
|
0.0 |
0.0 |
|
2.0 |
29.0 |
Notes: Data are not available for: Estonia, Norway, Turkey Injecting as a route of administration is not reported for cannabis (1) Last data available refer to 1999. (2) Data on percentage of clients injecting opiates only include heroin; data on injection are calculated on the total number of clients regardless the primary substance used. (3) Last data available refer to 2002. (4) Data on treatment demand referred to the annual census on clients in treatment carried out in November 2003. (5) Last data available refer to 2002. (6) Data on all clients refer to 9 treatment centres, for which data were available in 2003: 3 outpatient treatment centres, 3 inpatient treatment centres and 3 treatment units in prison (7) Data refer to clients in substitution treatment only; figures for opiates as main drug and injecting use are consequently 100%. (8) Last data available refer to 2002. (9) Only total number of clients is available for all treatments. (10) Data refer only to outpatient treatment centres. (11) Data relate to the period from 1 April 2002 to 31 March 2003 for Scotland and Northern Ireland; for England from April 2003 to March 2004; Wales: six months periods ending 30 September 2001 and 31 March 2002 combined. Sources: 2004 Reitox national reports - standard table 3 See [Table TDI-1] for details on sources. | ||||||||||||